Clinical Features and Clinical Course of Food Protein-Induced Allergic Proctocolitis: 10-Year Experience of a

Nur Senocak1, Aysegul Ertugrul2, Serap Ozmen2

  • 1Dr. Sami Ulus Maternity and Children Training and Research Hospital, Department of Pediatrics, University of Health Sciences, Ankara, Turkey.

Insights

Food protein-induced allergic proctocolitis (FPIAP) in infants often presents with bloody stools. Premature birth and formula use can affect symptom onset and tolerance development in FPIAP cases.

Area of Science:

  • Pediatric Allergy and Immunology
  • Gastroenterology
  • Clinical Nutrition

Background:

  • Food protein-induced allergic proctocolitis (FPIAP) is a non-IgE mediated gastrointestinal food allergy.
  • It is characterized by rectal bleeding in otherwise healthy infants, primarily breastfed.
  • Understanding FPIAP's clinical course is crucial for effective management.

Purpose of the Study:

  • To investigate the clinical course of FPIAP.
  • To identify factors influencing the development of tolerance to food proteins in FPIAP patients.
  • To analyze the impact of prematurity, birth history, and formula type on FPIAP.

Main Methods:

  • Retrospective analysis of FPIAP patients over a 10-year period.
  • Data collected from an Allergy-Immunology outpatient clinic at a tertiary care children's hospital.
  • Statistical analysis to determine associations between clinical factors and FPIAP course.

Main Results:

  • FPIAP occurred in 0.18% of patients; median onset at 2 months, tolerance at 12 months.
  • Neonatal symptoms linked to prematurity and NICU stay (OR 3.75, P=.031; OR 4.72, P=.002).
  • Formula use (cow's milk-based) associated with later onset (OR 2.69, P=.016); amino acid formula and diarrhea delayed tolerance (P=.023, P<.001).

Conclusions:

  • FPIAP symptoms manifest earlier in premature infants and later in formula-fed infants.
  • Amino acid-based formula and diarrhea are associated with delayed tolerance development in FPIAP.
  • These findings aid in predicting FPIAP course and guiding therapeutic interventions.
Abstract

Related Concept Videos

Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
554
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
390
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
443
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
263
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
435
Gastritis III: Clinical Manifestations and Management01:23

Gastritis III: Clinical Manifestations and Management

The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
556